Sarepta Therapeutics, Inc. (0L35.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.17B |
| Enterprise Value | 2.41B |
| P/E Ratio | -12.49 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0.96 |
| Price/Book Ratio | 1.24 |
| Enterprise/Revenue | 1.2 |
| Enterprise/EBITDA | -162.75 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.07 |
| Operating Margin | -0.07 |
AD
Management Effectiveness
| Return On Assets | -0.04 |
| Return On Equity | -0.1 |
Income Statement
| Revenue | 2.2B |
| Revenue/Share | 18.73 |
| Gross Profit | 1.32B |
| EBITDA | -599.3M |
| Net Income | -713.41M |
| Diluted EPS | -7.13 |
Balance Sheet
| Total Cash | 788.49M |
| Total Cash/Share | 7.48 |
| Total Debt | 1.05B |
| Total Debt/Equity | 0.68 |
| Current Ratio | 4.42 |
| Book Value Per Share | 14.49 |
Price History
| 52-Week Change | -7.79 |
| 52-Week High | 155.48 |
| 52-Week Low | 14.35 |
| Moving Average 50 Days | 121.03 |
| Moving Average 200 Days | 112.45 |
Statistics
| Average Volume | 424 |
| Shares Outstanding | 102.03M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
